|
(L1) 6501.264-Amoxicillin Trihydrate + Potassium Clavulanate, 500 + 125 Mg, Coated Tablet, Blister, Route Of Administration: Oral, Units. Size: Unit, (L2) 6501.300-Budesonide, 0.25 Mg/Ml, Suspension For Nebulization, Vial, 2 Ml, Route Of Administration: Inhalation, (L3) 6501.523-Deslanoside, 2 Mg/Ml, Injectable Solution, Ampoule , Route Of Administration: Intramuscular/Intravenous, (L4) 6501.586-Dimenhydrinate + Pyridoxine, Hydrochloride, 50 Mg + 50 Mg/Ml, 1 Ml, Route Of Administration: Intramuscular, (L5) 6501.1321-Glycerin, 120 Mg/Ml (12 %), Rectal Solution, Bag/Bottle, 500 Ml + Application Probe, Route Of Administration: Rectal, 11/09/2023, (L6) 6501.820-Levothyroxine Sodium, 75 Mcg, Tablet, (L7) 6501.836-Methylergometrine, Maleate , Route Of Administration: Subcutaneous/Intramuscular/Intravenous, (L8) 6501.4793-Milrinone, Lactate, 1 Mg/Ml, 10 Ml, Route Of Administration: Intravenous, (L9) 6502.1180-Periciazine, 10 Mg/Ml (1%), Drops Solution, Drip Bottle, 20 Ml, Ordinance 344/98: C1, (L10) 6502.1181-Periciazine, 40 Mg/Ml (4%), (L11) 6502.1185-Proxymetacaine, 5 Mg/Ml, Ophthalmic Solution, 5Ml, Via Of Administration: Ophthalmic, (L12) 6501.45713-Rifampicin, 300 Mg, Capsule, (L13) 6502.1171-Nitrazepam, 5 Mg, Ordinance 344/98: B1, (L14) 6501.1784-Ropivacaine, Route Of Administration: Other Parenteral Routes
|
